Anti-inflammatory effects of the willow bark extract STW 33-I (Proaktiv) in LPS-activated human monocytes and differentiated macrophages

Introduction - Willow bark extract is frequently used in the treatment of painful rheumatological diseases, such as arthritis and back pain. Its effect has been attributed to its main component salicin, but pharmacological studies have shown that the clinical efficacy of the willow bark extract cann...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bonaterra, Gabriel (VerfasserIn) , Heinrich, E. U. (VerfasserIn) , Kelber, O. (VerfasserIn) , Weiser, D. (VerfasserIn) , Metz, Jürgen (VerfasserIn) , Kinscherf, Ralf (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 31 May 2010
In: Phytomedicine
Year: 2010, Jahrgang: 17, Heft: 14, Pages: 1106-1113
ISSN:1618-095X
DOI:10.1016/j.phymed.2010.03.022
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.phymed.2010.03.022
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0944711310001145
Volltext
Verfasserangaben:G.A. Bonaterra, E.U. Heinrich, O. Kelber, D. Weiser, J. Metz, R. Kinscherf

MARC

LEADER 00000caa a2200000 c 4500
001 1833707192
003 DE-627
005 20230710160632.0
007 cr uuu---uuuuu
008 230208s2010 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.phymed.2010.03.022  |2 doi 
035 |a (DE-627)1833707192 
035 |a (DE-599)KXP1833707192 
035 |a (OCoLC)1389821958 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bonaterra, Gabriel  |e VerfasserIn  |0 (DE-588)1120132622  |0 (DE-627)873220714  |0 (DE-576)480136173  |4 aut 
245 1 0 |a Anti-inflammatory effects of the willow bark extract STW 33-I (Proaktiv) in LPS-activated human monocytes and differentiated macrophages  |c G.A. Bonaterra, E.U. Heinrich, O. Kelber, D. Weiser, J. Metz, R. Kinscherf 
264 1 |c 31 May 2010 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.02.2023 
520 |a Introduction - Willow bark extract is frequently used in the treatment of painful rheumatological diseases, such as arthritis and back pain. Its effect has been attributed to its main component salicin, but pharmacological studies have shown that the clinical efficacy of the willow bark extract cannot be explained by its salicin content alone. Therefore different modes of action have been suggested for the anti-inflammatory effect of willow bark extract. Here, we report in vitro data revelling the effect and mode of action of the aqueous willow bark extract STW 33-I as well as a water-soluble fraction (fraction E [Fr E]) in comparison with well-known non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin (ASA) and diclofenac (Diclo) on pro-inflammatorily activated human monocytes and differentiated macrophages. - Results - STW 33-I and the water-soluble Fr E showed concentration-dependent and significant anti-inflammatory effects in lipopolysaccharide-activated monocytes. Both inhibited the intracellular protein expression of tumour necrosis factor-alpha (TNFα) as well as the mRNA expression of TNFα and cyclooxygenase 2 (COX-2), and the release of nitric oxide (NO). In addition, apoptosis of pro-inflammatorily activated monocytes was induced. Furthermore, treatment of activated macrophages with STW 33-I inhibited the nuclear translocation of the p65 subunit of the nuclear transcription factor-kappa B (NF-κB p65). - Conclusions - The present in vitro investigations suggest a significant anti-inflammatory activity of willow bark water extract STW 33-1 and of its water-soluble fraction by inhibiting pro-inflammatory cytokines (TNFα), COX-2 and nuclear translocation of the transcription factor NF-κB in pro-inflammatorily activated monocytes. Our results provide further evidence for the therapeutic use of STW 33-I in inflammation-related disorders. 
650 4 |a Cyclooxygenase 
650 4 |a Inflammation 
650 4 |a Macrophage 
650 4 |a Monocyte 
650 4 |a NF-κB 
650 4 |a TNFα 
650 4 |a Willow bark 
700 1 |a Heinrich, E. U.  |e VerfasserIn  |4 aut 
700 1 |a Kelber, O.  |e VerfasserIn  |4 aut 
700 1 |a Weiser, D.  |e VerfasserIn  |4 aut 
700 1 |a Metz, Jürgen  |d 1943-  |e VerfasserIn  |0 (DE-588)1019940506  |0 (DE-627)691057354  |0 (DE-576)359171109  |4 aut 
700 1 |a Kinscherf, Ralf  |e VerfasserIn  |0 (DE-588)1084823748  |0 (DE-627)848747925  |0 (DE-576)169729516  |4 aut 
773 0 8 |i Enthalten in  |t Phytomedicine  |d München [u.a.] : Elsevier, 1994  |g 17(2010), 14, Seite 1106-1113  |h Online-Ressource  |w (DE-627)325793352  |w (DE-600)2040195-4  |w (DE-576)116691972  |x 1618-095X  |7 nnas  |a Anti-inflammatory effects of the willow bark extract STW 33-I (Proaktiv) in LPS-activated human monocytes and differentiated macrophages 
773 1 8 |g volume:17  |g year:2010  |g number:14  |g pages:1106-1113  |g extent:8  |a Anti-inflammatory effects of the willow bark extract STW 33-I (Proaktiv) in LPS-activated human monocytes and differentiated macrophages 
856 4 0 |u https://doi.org/10.1016/j.phymed.2010.03.022  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0944711310001145  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230208 
993 |a Article 
994 |a 2010 
998 |g 1084823748  |a Kinscherf, Ralf  |m 1084823748:Kinscherf, Ralf  |p 6  |y j 
998 |g 1019940506  |a Metz, Jürgen  |m 1019940506:Metz, Jürgen  |d 50000  |d 53100  |e 50000PM1019940506  |e 53100PM1019940506  |k 0/50000/  |k 1/50000/53100/  |p 5 
998 |g 1120132622  |a Bonaterra, Gabriel  |m 1120132622:Bonaterra, Gabriel  |p 1  |x j 
999 |a KXP-PPN1833707192  |e 4268623035 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Anti-inflammatory effects of the willow bark extract STW 33-I (Proaktiv) in LPS-activated human monocytes and differentiated macrophages","title_sort":"Anti-inflammatory effects of the willow bark extract STW 33-I (Proaktiv) in LPS-activated human monocytes and differentiated macrophages"}],"person":[{"roleDisplay":"VerfasserIn","display":"Bonaterra, Gabriel","role":"aut","family":"Bonaterra","given":"Gabriel"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Heinrich, E. U.","given":"E. U.","family":"Heinrich"},{"family":"Kelber","given":"O.","display":"Kelber, O.","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Weiser, D.","role":"aut","family":"Weiser","given":"D."},{"display":"Metz, Jürgen","roleDisplay":"VerfasserIn","role":"aut","family":"Metz","given":"Jürgen"},{"family":"Kinscherf","given":"Ralf","display":"Kinscherf, Ralf","roleDisplay":"VerfasserIn","role":"aut"}],"note":["Gesehen am 08.02.2023"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1833707192","language":["eng"],"origin":[{"dateIssuedDisp":"31 May 2010","dateIssuedKey":"2010"}],"id":{"eki":["1833707192"],"doi":["10.1016/j.phymed.2010.03.022"]},"name":{"displayForm":["G.A. Bonaterra, E.U. Heinrich, O. Kelber, D. Weiser, J. Metz, R. Kinscherf"]},"physDesc":[{"extent":"8 S."}],"relHost":[{"id":{"eki":["325793352"],"zdb":["2040195-4"],"issn":["1618-095X"]},"origin":[{"publisherPlace":"München [u.a.] ; Jena","dateIssuedDisp":"1994-","dateIssuedKey":"1994","publisher":"Elsevier ; Urban & Fischer"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Phytomedicine","title":"Phytomedicine","subtitle":"international journal of phytotherapy and phytopharmacology"}],"part":{"pages":"1106-1113","issue":"14","year":"2010","extent":"8","volume":"17","text":"17(2010), 14, Seite 1106-1113"},"pubHistory":["1.1994/95 -"],"recId":"325793352","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Anti-inflammatory effects of the willow bark extract STW 33-I (Proaktiv) in LPS-activated human monocytes and differentiated macrophagesPhytomedicine","note":["Fortsetzung der Druckausgabe","Gesehen am 13.06.2023"]}]} 
SRT |a BONATERRAGANTIINFLAM3120